Crestwood Advisors Group’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,452
| Closed | -$488K | – | 899 |
|
|
2026
Q1 | $488K | Buy |
6,452
+283
| +5% | +$21.3K | 0.01% | 428 |
|
|
2025
Q4 | $460K | Buy |
6,169
+1,664
| +37% | +$122K | 0.01% | 416 |
|
|
2025
Q3 | $304K | Sell |
4,505
-1,054
| -19% | -$70K | 0.01% | 465 |
|
|
2025
Q2 | $362K | Buy |
5,559
+664
| +14% | +$39.8K | 0.01% | 400 |
|
|
2025
Q1 | $302K | Sell |
4,895
-31
| -0.6% | -$2.05K | 0.01% | 423 |
|
|
2024
Q4 | $355K | Sell |
4,926
-337
| -6% | -$26.3K | 0.01% | 356 |
|
|
2024
Q3 | $429K | Buy |
5,263
+69
| +1% | +$5.52K | 0.01% | 317 |
|
|
2024
Q2 | $386K | Sell |
5,194
-14
| -0.3% | -$1.05K | 0.01% | 316 |
|
|
2024
Q1 | $406K | Buy |
5,208
+37
| +0.7% | +$2.75K | 0.01% | 307 |
|
|
2023
Q4 | $369K | Buy |
5,171
+1,155
| +29% | +$80.4K | 0.01% | 302 |
|
|
2023
Q3 | $279K | Buy |
+4,016
| New | +$303K | 0.01% | 303 |
|
|
2019
Q4 | – | Sell |
-33,204
| Closed | -$68K | – | 260 |
|
|
2019
Q3 | $68K | Hold |
33,204
| – | – | ﹤0.01% | 250 |
|
|
2019
Q2 | $66K | Buy |
33,204
+646
| +2% | +$29.9K | ﹤0.01% | 235 |
|
|
2019
Q1 | $35K | Buy |
32,558
+54
| +0.2% | +$2.44K | ﹤0.01% | 175 |
|
|
2018
Q4 | $33K | Hold |
32,504
| – | – | ﹤0.01% | 161 |
|
|
2018
Q3 | $33K | Hold |
32,504
| – | – | ﹤0.01% | 173 |
|
|
2018
Q2 | $33K | Hold |
32,504
| – | – | ﹤0.01% | 175 |
|
|
2018
Q1 | $33K | Hold |
32,504
| – | – | ﹤0.01% | 177 |
|
|
2017
Q4 | $33K | Hold |
32,504
| – | – | ﹤0.01% | 189 |
|
|
2017
Q3 | $33K | Hold |
32,504
| – | – | ﹤0.01% | 165 |
|
|
2017
Q2 | $33K | Hold |
32,504
| – | – | ﹤0.01% | 158 |
|
|
2017
Q1 | $33K | Buy |
+32,504
| New | +$1.33M | ﹤0.01% | 314 |
|
Other funds holding HOLX
Crestwood Advisors Group's HOLX Position: Q2 2026 in Review
Crestwood Advisors Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 6,452 shares — an estimated $488K sold.
Crestwood Advisors Group first reported a position in HOLX in Q1 2017 and held it in 22 quarters. The position peaked at $488K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Crestwood Advisors Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Crestwood Advisors Group sold 6,452 Hologic shares in Q2 2026, an estimated $488K.
- Crestwood Advisors Group first reported a position in Hologic in Q1 2017 and held it in 22 quarters.
- Crestwood Advisors Group's Hologic position peaked at $488K in Q1 2026.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.